Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

Sitagliptin, a modern antidiabetic agent which is weight neutral and associated with low rate of hypoglycaemias, is being increasingly used in type 2 diabetes mellitus (DM). However there is paucity of data about its efficacy and safety in beta-thalassaemia major (β-TM). This retrospective case ser...

Full description

Bibliographic Details
Main Author:	Shahrzad Zonoozi
Format:	Article
Language:	English
Published:	Mattioli1885 2017-01-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Thalassemic Syndromes, Diabetes
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/2751

Similar Items

Transfusion-related acute lung injury (TRALI) in two thalassaemia patients caused by the same multiparous blood donor
by: George J Kontoghiorghes
Published: (2017-10-01)

B- THALASSEMIA MAJOR IN RAMADI
by: Zeina H Al Shemmari, et al.
Published: (2005-07-01)

GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
by: Naouel GUIRAT
Published: (2018-05-01)

NATIONAL THALASSEMIA PREVENTION CAMPAIGN: PROJECT OF TALOTIR
by: Duran Canatan, et al.
Published: (2014-08-01)

Glucose homeostasis in Egyptian children and adolescents with β-Thalassemia major: Relationship to oxidative stress
by: Kotb Abbass Metwalley, et al.
Published: (2014-01-01)

prevalence of hepatitis B among thalassemic patients in Kerman
by: A.A Vahidi, et al.
Published: (1997-07-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
by: Alaa Efat, et al.
Published: (2022-05-01)

Cw alloimmunization in multitransfused thalassemic patients of North India: Prevalence and approach to transfusion
by: Sangeeta Pahuja, et al.
Published: (2022-01-01)

Direct antiglobulin test positivity in multi-transfused thalassemics
by: Ashish Jain, et al.
Published: (2016-01-01)

Double Heterozygous Hemoglobin Q India/ Hemoglobin D Punjab Hemoglobinopathy: Report of Two Rare Cases
by: Deepti Mutreja, et al.
Published: (2014-08-01)

Effect of iron overload on furin expression in wild-type and β-thalassemic mice
by: Surasak Wichaiyo, et al.
Published: (2015-01-01)

Prevalence of hepatitis C among thalassemic patients reffering to Kerman university of medical sciences hospital NO:1 in 1996
by: A.A Vahidi, et al.
Published: (2000-07-01)

The hypoferremic response to acute inflammation is maintained in thalassemia mice even under parenteral iron loading
by: Chanita Sanyear, et al.
Published: (2021-04-01)

Effectiveness of Cognitive Therapy Based on Mindfulness on Perceived Stress, Resilience and Quality of Life in Thalassemic Major Patients
by: fariborz jabbarifard, et al.
Published: (2019-02-01)

Association between hepatitis C infection and number of screened blood unit transfusions in thalassemic children
by: Diah Asri Wulandari, et al.
Published: (2016-10-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Cut off Determination of Discrimination Indices in Differential Diagnosis between Iron Deficiency Anemia and β- Thalassemia Minor
by: Ebrahim Miri-Moghaddam, et al.
Published: (2014-06-01)

Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
by: Giuseppe Leone, et al.
Published: (2009-06-01)

Safety and Efficacy of Sitagliptin compared with Glimepiride in Patients with Type 2 Diabetes Mellitus inadequately controlled with Metfromin Monotherapy
by: Amjad Abrar, et al.
Published: (2013-07-01)

Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients
by: Antonio Asti, et al.
Published: (2016-03-01)

ADVANTAGES, SAFETY AND PROSPECTS OF SITAGLIPTIN APPLICATION IN TYPE 2 DIABETES MELLITUS WITH CHRONIC KIDNEY DISEASE
by: I. A. Bonda
Published: (2017-07-01)

Prevalence of Hepatitis C in Beta Thalassaemia Major
by: Hamid Hussain, et al.
Published: (2004-06-01)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
by: Le TD, et al.
Published: (2020-06-01)

Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
by: Soon Ae Kim, et al.
Published: (2011-04-01)

Myocardial infarction in patients with severe beta thalassaemia: a case series
by: Anuja Premawardhena, et al.
Published: (2023-03-01)

Frequency of Glomerular Dysfunction in Children with Beta Thalassaemia Major
by: Basma A. Ali, et al.
Published: (2014-02-01)

Psychosocial Status In Iranian Adolescents With Beta-Thalassaemia Major
by: Khodai S, et al.
Published: (2005-05-01)

Comparative treatment between sitagliptin vs. metformin, alone or in combination, in patients with polycystic ovary syndrome. A clinical entity at high risk for developing diabetes mellitus and gestational diabetes: A pilot study
by: J.C. Paredes Palma, et al.
Published: (2018-01-01)

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
by: Engel Samuel S, et al.
Published: (2013-01-01)

The durability of sitagliptin in elderly patients with type 2 diabetes
by: Hsieh CJ, et al.
Published: (2014-11-01)

Beta-talasemi major komplikasyonu olarak gelişen diabetes mellitus ve hipoparatiroidi
by: Ayşe Özlem Kılıçaslan, et al.
Published: (2014-01-01)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-09-01)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-01-01)

Nutritional management of diabetes mellitus and dysmetabolic syndrome /
by: Bantle, John P., 1947-, et al.
Published: (2006)

Red Cell Alloantibodies in Multi - Transfused Patients of Beta Thalassaemia Major
by: Madeeha Rehan
Published: (2015-06-01)

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
by: Masahiro Fukuda, et al.
Published: (2019-03-01)

Screening of Alpha-Thalassaemia 1 in Beta-Thalassaemia Carriers
by: Chong, Yi Min
Published: (2005)

Oxidative stress injury and glucolipotoxicity in type 2 diabetes mellitus: The potential role of metformin and sitagliptin
by: May Hassan Abdul-Hadi, et al.
Published: (2020-01-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01)

Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
by: Tong Lin, et al.
Published: (2022-09-01)